Harmony Biosciences Holdings, Inc. HRMY Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s accounts receivable?
- Harmony Biosciences Holdings, Inc. (HRMY) reported accounts receivable of $108.22M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s accounts receivable changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s accounts receivable increased by 2.1% year-over-year, from $105.97M to $108.22M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s accounts receivable?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s accounts receivable has grown at a 34.0% compound annual growth rate (CAGR), from $122.86M to $396.39M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.